• Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibito...

• Lee Jung-Yun

• Lee Yoo-Young, Park Jeong-Yeol, Shim Seung-Hyuk, Kim Se-Ik, Kong Tae-Wook, Lim Chul-Kwon, ...

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 51 ~ 51

• Incidence and treatment outcomes of uterine cervical cancer in Korea 1999?2018 from the national can...

• Suh Dong-Hoon

• Ha Hyeong-In, Lee Yeon-Jee, Lim Ji-Won, Won Young-Joo, Lim Myong-Cheol

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 39 ~ 39

• Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial canc...

• Yang Li

• Changkun Zhu, Hongyu Xie, Yaxia Chen, Weiguo Lv, Xing Xie, Xinyu Wang

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 37 ~ 37

• Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a s...

• Hongyi Wei

• Ningning Pan, Wen Zhang, Guangwu Xiong, Wenping Guo, Caihong Ma

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 36 ~ 36

• The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women¡¯...

• David Tan

• Noriko Fujiwara, Keiichi Fujiwara, Philip Beale, Kim Jae-Weon, Alison Evans, Kim Byoung-Gie

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 33 ~ 33

• Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgi...

• Alberto Rafael Guijarro-Campillo

• Blanca Segarra Vidal, Victor Lago, Pablo Padilla-Iserte, Josselyn Andrea Hernandez Chinchilla, Ivan ...

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 21 ~ 21

• Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for...

• Cong Liang

• Ping Liu, Shan Kang, Weili Li, Biliang Chen, Mei Ji, Chunlin Chen

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 20 ~ 20

• CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-127...

• Yan Wu

• Fuhua Wang, Jing Shi, Xiangyun Guo, Feng Li

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 19 ~ 19

• Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable...

• Hong Jin-Hwa

• Cho Hyun-Woong, Ouh Yung-Taek, Lee Jae-Kwan, Chun Yi-Kyeong

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 18 ~ 18

• Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer

• Lee Yong-Jae

• Chung Young-Shin, Lee Jung-Yun, Nam Eun-Ji, Kim Sang-Wun, Kim Young-Tae, Kim Sung-Hoon

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 17 ~ 17

• Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma

• Deniz Ar©¥k

• Tutku Benli, Elcin Telli

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 16 ~ 16

• A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metf...

• John P. Micha

• Mark A. Rettenmaier, Randy D. Bohart, Bram H. Goldstein

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 15 ~ 15

• Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese...

• Eiko Saitoh Aoki

• Kumiko Saika, Kazushige Kiguchi, Tohru Morisada, Daisuke Aoki

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 14 ~ 14

• Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on ...

• Xinyu Qu

• Junjun Qiu, Lili Jiang, Xiaorong Qi, Guonan Zhang, Weiwei Feng, Yudong Wang, Yincheng Teng...

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 13 ~ 13

• Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin ...

• Ran Chu

• Penglin Liu, Jingying Chen, Xiaodong Cheng, Kezhen Li, Yanci Che, Jianliu Wang, Li Li,&nbs...

• Journal of Gynecologic Oncology   2023  Volume.34  No.2 12 ~ 12